Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume

Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 52,600 shares of EVAX short. Learn More on Evaxion Biotech A/S's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVAX shares currently have a short interest ratio of 1.0. Learn More on Evaxion Biotech A/S's short interest ratio.

Evaxion Biotech A/S saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 52,600 shares, a drop of 22.0% from the previous total of 67,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Evaxion Biotech A/S: Passage Bio, Inc. (3.21%), Estrella Immunopharma, Inc. (0.06%), Surrozen, Inc. (1.47%), SAB Biotherapeutics, Inc. (0.79%), MiNK Therapeutics, Inc. (0.52%), Pluri Inc. (0.24%), Athira Pharma, Inc. (4.38%), Calidi Biotherapeutics, Inc. (7.72%), Curis, Inc. (1.84%), Cyclo Therapeutics, Inc. (0.69%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is October, 31 2024.